Press release
Knee Osteoarthritis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight
Stay ahead with the latest insights! Download DelveInsight's comprehensive Knee Osteoarthritis Pipeline Report to explore emerging therapies, key Knee Osteoarthritis Companies, and future Knee Osteoarthritis treatment landscapes @ Knee Osteoarthritis Pipeline Outlook Report [https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Knee Osteoarthritis Pipeline Report
* In February 2025:- Medipost Co. Ltd :- This clinical trial is for patients who have been diagnosed with Kellgren-Lawrence (K&L) Grade 2 or 3 knee osteoarthritis on radiographic examination. Only subjects who voluntarily agree to participate by filling out the written Informed Consent document will undergo screening for subject selection (inclusion/exclusion) criteria, at which time the severity of OA in each knee will be used to determined which knee will be treated (index knee - i.e., the more severely affected knee), and enroll in this study.
* In January 2025:- Novartis Pharmaceuticals :- The purpose of this study is to evaluate the articular cartilage-regenerating capacity of RHH646 in the knee as well as to assess safety and tolerability in participants with knee osteoarthritis. The treatment duration will be up to 52 weeks. The total study duration for an individual participant will be up to 62 weeks.
* In January 2025:- ArthroBiologix Inc .:- The purpose of this study is to determine whether outcomes for patients receiving intra-articular platelet-rich plasma (PRP) injections for knee osteoarthritis are influenced by observation of the preparatory steps to the procedure. The viewing of the steps involved in the administration of PRP may increase the effectiveness of the treatment in comparison to patients who have not observed the preparatory steps.
* DelveInsight's Knee Osteoarthritis pipeline report depicts a robust space with 50+ active players working to develop 60+ pipeline therapies for Knee Osteoarthritis treatment.
* The leading Knee Osteoarthritis Companies such as Bone Therapeutics, Moebius Medical, UnicoCell Biomed CO. LTD, Gwo Xi Stem Cell Applied Technology, Bioventus LLC, CAR-T (Shanghai) Biotechnology, Novartis, Personalized Stem Cells, Centrexion Therapeutics, Akan Biosciences, Samumed LLC, Purdue Pharma, Anika Therapeutics, Peptinov SAS, Flexion Therapeutics, Centrexion Therapeutics, Taiwan Liposome Company, Techfields Pharma, AstraZeneca, Ampio Pharmaceuticals, BioIntegrate, Sorrento Therapeutics, Swiss Medica XXI Century S.A., OrthoTrophix, R-Bio, Amzell, Eupraxia Pharmaceuticals, Meluha Life Sciences SDN BHD, Vivex Biomedical, Orient Europharma Co., Ltd., Paradigm Biopharmaceuticals, AbbVie, Galapagos NV, Regeneron Pharmaceuticals, Xalud Therapeutics, Yooyoung Pharmaceutical, Eupraxia Pharmaceuticals, Celltex Therapeutics Corporation, Eli Lilly and Company, Sclnow Biotechnology, Mestex AG, Mitsubishi Tanabe Pharma Corporation, Propella Therapeutics, PT. Prodia Stem Cell Indonesia and others.
* Promising Knee Osteoarthritis Therapies such as Civamide, Clodronate, LBSA0103, Glucosamine and chondroitin sulfate combination (Eurofarma), RN624 (PF-04383119) and others.
Discover how the Knee Osteoarthritis treatment paradigm is evolving. Access DelveInsight's in-depth Knee Osteoarthritis Pipeline Analysis for a closer look at promising breakthroughs @ Knee Osteoarthritis Clinical Trials and Studies [https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Knee Osteoarthritis Emerging Drugs Profile
* Lorecivivint: Biosplice Therapeutics
Lorecivivint (SM04690) is a small-molecule CLK/DYRK1A inhibitor that modulates Wnt and inflammatory pathways and is in development as a potential disease-modifying osteoarthritis drug. Vehicle-controlled preclinical data suggest that lorecivivint has a dual mechanism of action with three potential effects on joint health: reduction of inflammation, slowing of cartilage breakdown, and generation of cartilage. Currently, the drug is in Phase III stage of its development for the treatment of Knee Osteoarthritis.
* EP-104IAR: Eupraxia Pharmaceuticals Inc.
EP-104IAR, is designed to meet the significant unmet medical need and market demand for long-lasting disease relief in multiple indications benefitting from highly localized and longer delivery of corticosteroids. The lead indication is for pain relief in knee OA. With EP-104IAR, Eupraxia hopes to change the way knee OA pain is treated. Currently approved corticosteroids are very effective at reducing pain for a short duration late in the disease but can expose the body to unwanted local and systemic side effects. EP-104IAR is designed to prolong the duration of pain relief with fewer unwanted side effects. It encapsulates a highly potent corticosteroid (fluticasone propionate) within a microns-thin polymer membrane, part of Eupraxia's patented technology platform. Injected into the knee, EP-104IAR is designed to diffuse the corticosteroid slowly into the knee joint providing local therapeutic concentrations for up to six months. This has the potential dual advantage of providing longer duration of pain relief with fewer systemic side effects. A robust safety and tolerability profile would also benefit the estimated 70% of knee OA patients that experience pain in both knees by allowing simultaneous treatment of both affected joints. Currently, the drug is in Phase II stage of its development for the treatment of Knee Osteoarthritis.
* LG00034053: LG Chem
LG34053 is an injectable new drug with a new mechanism of blocking the inflammatory pathway and inhibiting chondrocyte apoptosis. LG Chem expects that the new drug will be different from existing symptomatic pain relief drugs. LG00034053 is the world's first injection-type new drug that blocks inflammatory pathways and inhibits cartilage cell death. Preclinical results showed that the pain relief effect lasted for several months with just one administration, and it also improved effects on cartilage damage, the root cause of arthritis. It has showed the possibility of developing a new drug that is different from existing pain relief symptomatic drugs. Currently, the drug is in Phase I/II stage of its development for the treatment of Knee Osteoarthritis.
Get a detailed analysis of the latest innovations in the Knee Osteoarthritis pipeline. Explore DelveInsight's expert-driven report today! @ Knee Osteoarthritis Unmet Needs [https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Knee Osteoarthritis Companies
Bone Therapeutics, Moebius Medical, UnicoCell Biomed CO. LTD, Gwo Xi Stem Cell Applied Technology, Bioventus LLC, CAR-T (Shanghai) Biotechnology, Novartis, Personalized Stem Cells, Centrexion Therapeutics, Akan Biosciences, Samumed LLC, Purdue Pharma, Anika Therapeutics, Peptinov SAS, Flexion Therapeutics, Centrexion Therapeutics, Taiwan Liposome Company, Techfields Pharma, AstraZeneca, Ampio Pharmaceuticals, BioIntegrate, Sorrento Therapeutics, Swiss Medica XXI Century S.A., OrthoTrophix, R-Bio, Amzell, Eupraxia Pharmaceuticals, Meluha Life Sciences SDN BHD, Vivex Biomedical, Orient Europharma Co., Ltd., Paradigm Biopharmaceuticals, AbbVie, Galapagos NV, Regeneron Pharmaceuticals, Xalud Therapeutics, Yooyoung Pharmaceutical, Eupraxia Pharmaceuticals, Celltex Therapeutics Corporation, Eli Lilly and Company, Sclnow Biotechnology, Mestex AG, Mitsubishi Tanabe Pharma Corporation, Propella Therapeutics, PT. Prodia Stem Cell Indonesia and others.
Knee Osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Intravenous
* Subcutaneous
* Parenteral
* Topical
Knee Osteoarthritis Products have been categorized under various Molecule types such as
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
Download DelveInsight's latest report to gain strategic insights into upcoming Knee Osteoarthritis Therapies and key Knee Osteoarthritis Developments @ Knee Osteoarthritis Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Knee Osteoarthritis Pipeline Report
* Coverage- Global
* Knee Osteoarthritis Companies- Bone Therapeutics, Moebius Medical, UnicoCell Biomed CO. LTD, Gwo Xi Stem Cell Applied Technology, Bioventus LLC, CAR-T (Shanghai) Biotechnology, Novartis, Personalized Stem Cells, Centrexion Therapeutics, Akan Biosciences, Samumed LLC, Purdue Pharma, Anika Therapeutics, Peptinov SAS, Flexion Therapeutics, Centrexion Therapeutics, Taiwan Liposome Company, Techfields Pharma, AstraZeneca, Ampio Pharmaceuticals, BioIntegrate, Sorrento Therapeutics, Swiss Medica XXI Century S.A., OrthoTrophix, R-Bio, Amzell, Eupraxia Pharmaceuticals, Meluha Life Sciences SDN BHD, Vivex Biomedical, Orient Europharma Co., Ltd., Paradigm Biopharmaceuticals, AbbVie, Galapagos NV, Regeneron Pharmaceuticals, Xalud Therapeutics, Yooyoung Pharmaceutical, Eupraxia Pharmaceuticals, Celltex Therapeutics Corporation, Eli Lilly and Company, Sclnow Biotechnology, Mestex AG, Mitsubishi Tanabe Pharma Corporation, Propella Therapeutics, PT. Prodia Stem Cell Indonesia and others.
* Knee Osteoarthritis Therapies- Civamide, Clodronate, LBSA0103, Glucosamine and chondroitin sulfate combination (Eurofarma), RN624 (PF-04383119) and others.
* Knee Osteoarthritis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Knee Osteoarthritis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Which companies are leading the race in Knee Osteoarthritis drug development? Find out in DelveInsight's exclusive Knee Osteoarthritis Pipeline Report-access it now! @ Knee Osteoarthritis Emerging Drugs and Major Companies [https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Knee Osteoarthritis: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Knee Osteoarthritis - DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* Lorecivivint: Biosplice Therapeutics
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* EP-104IAR: Eupraxia Pharmaceuticals Inc
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I/II)
* LG00034053: LG Chem
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Knee Osteoarthritis Key Companies
* Knee Osteoarthritis Key Products
* Knee Osteoarthritis Unmet Needs
* Knee Osteoarthritis Market Drivers and Barriers
* Knee Osteoarthritis Future Perspectives and Conclusion
* Knee Osteoarthritis Analyst Views
* Knee Osteoarthritis Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=knee-osteoarthritis-clinical-trials-and-studies-ema-pdma-fda-approvals-mechanism-of-action-roa-nda-ind-and-companies-by-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/tay-sachs-disease-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Knee Osteoarthritis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight here
News-ID: 3860790 • Views: …
More Releases from ABNewswire
Denver's Best Appliance Repair Responds to Rising Demand for Emergency Appliance …
Denver's Best Appliance Repair expands emergency services across the Denver metro with same-day repairs, 7-day availability, 5-year parts warranty, and professional licensed technicians serving residential and commercial clients.
Household appliance failures don't follow a schedule. When a refrigerator stops cooling in the middle of summer or a washing machine floods a basement on a Sunday evening, families need immediate help. Denver's Best Appliance Repair has responded to this growing need by…
Oak Hill Clinic Reaches 30,000 Client Milestone with Results-Driven Deep Tissue …
Deep Relief in Oak Hill, Austin, has served 30,000 clients through specialized massage, chiropractic, and acupuncture care. The clinic accepts insurance and focuses on results-driven treatments for pain relief.
Deep Relief, an Oak Hill-based wellness clinic, has achieved a significant milestone by serving more than 30,000 clients seeking Relief from chronic pain, muscle tension, and mobility issues. The clinic's success stems from its commitment to advanced, results-focused bodywork that goes beyond…
Vertex Fleet Expands Nationwide Network to Combat Growing Trailer Drop Yard Shor …
Vertex Fleet announces major expansion of secure parking facilities nationwide, addressing the critical shortage of commercial vehicle storage with 15+ new locations featuring 24/7 security and technology-driven access.
The freight and logistics industry faces a mounting crisis as demand for secure parking spaces continues to outpace supply across the United States. Vertex Fleet [https://www.vertexfleet.com/], a leading provider of industrial outdoor storage solutions, has announced significant expansion plans to address this critical…
HVAC in Denver Sees Service Enhancement as Denver's Best Heating and AC Repair L …
Denver's Best Heating and AC Repair expands 24/7 emergency services across 23 metro cities, offering A+ rated heating, cooling, and commercial HVAC solutions with rapid response times and multi-brand expertise.
Denver's Best Heating and AC Repair [https://www.denversbestheatingandacrepair.com/]has expanded its service capabilities to meet growing demand for reliable heating and cooling solutions across the Denver Metro area. The A+ rated contractor now provides 24/7 emergency response services to 23 cities, addressing critical…
More Releases for Knee
Knee Pain Relief Codes: The Ultimate Guide to Overcoming Knee Pain Naturally
The Knee Pain Relief Codes is a comprehensive online program designed to help individuals prevent and alleviate knee pain through proactive and natural methods. It provides valuable information on maintaining knee health, strengthening knee joints, and managing pain effectively. The program focuses on relieving joint discomfort, stiffness, and knee osteoarthritis using simple yet powerful exercises and techniques.
While knee pain is common, some conditions like knee osteoarthritis and joint injuries can…
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important U …
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important Update About Nooro Knee Massager, Buyers Beware!!!
Introducing the groundbreaking Nooro Knee Massager - a cutting-edge solution meticulously designed by leading knee pain experts. Experience unparalleled relief precisely when you need it, as this revolutionary device combines Red Light Therapy, Heat Therapy, and Massage Therapy for a holistic approach to knee discomfort. Not only is it remarkably cost-effective, but…
NOORO KNEE MASSAGER REVIEW 2023: BUYERS BEWARE! IS NOORO KNEE MASSAGER LEGIT?
In a world where knee discomfort has become increasingly prevalent, seeking effective solutions for pain relief has never been more important. Middle-aged and older individuals, in particular, often find themselves grappling with knee pain, hindering their daily activities and overall quality of life. This is where the Nooro Knee Massager steps in as a beacon of hope, offering targeted relief and relaxation for weary and sore knees. In this comprehensive…
Knee Walker Market - Revolutionizing Rehabilitation: Knee Walker's Impact on the …
Newark, New Castle, USA: The "Knee Walker Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Knee Walker Market: https://www.growthplusreports.com/report/knee-walker-market/8893
This latest report researches the industry structure, sales, revenue,…
Knee Sleeve Review 2022: (Must Read!) Is Knee Sleeve Working or Fake?
As people become older, the lubrication that surrounds their knee caps wears off, making them more susceptible to injury.
The pain may eventually become intolerable with long-distance walking, frequent use of the knee, particularly on rough surfaces, and other daily activities.
When this happens, a person can discover that they are unable to continue with their regular routines.
To solve this problem, get our Knee Sleeves and use them in…
Knee Orthosis Market Increasing Demand By Type: With Knee Pads, Knee Has Opening …
Acumen Research and Consulting has announced the addition of the "Knee Orthosis Market” report to their offering.
The Knee Orthosis Market Report 2018 is an in depth study analyzing the current state of the Knee Orthosis Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Knee Orthosis Market provides analysis of China market covering the industry trends, recent…
